AKT1 and glioblastoma: As shown in Fig. 6A, overexpression of SLC25A32 increased p-AKT (Ser473) and p-mTOR (Ser2448) protein expression in GBM#BG5 cells (Fig. 6A), whereas knockdown SLC25A32 decreased p-AKT (Ser473) and p-mTOR (Ser2448) protein expression in both LN229 and GBM#P3 cells (Fig. 6A).